Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|September 26, 2022
Efficacy and safety of CD19 CAR-T cell therapy for patients with B cell acute lymphoblastic leukemia involving extramedullary relapseLuo Huang, Mingming Zhang, Guoqing Wei, et al.
European Journal of Haematology|July 21, 2023
Donor-derived stem cell infusion for sustained pancytopenia after CD19 CAR-T therapy for relapsed patients post allogeneic stem cell transplantationYingying Li, Yixue Li, Mingming Zhang, et al.
Frontiers of Medicine|December 1, 2020
A giant step forward: chimeric antigen receptor T-cell therapy for lymphomaHouli Zhao, Yiyun Wang, Elaine Tan Su Yin, et al.
Expert Opinion on Biological Therapy|July 2, 2020
CAR-T cells: the Chinese experienceLinqin Wang, Elaine Tan Su Yin, Houli Zhao, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple MyelomaCheng Zu, Yufeng Xu, Yiyun Wang, et al.
Cell Transplantation|April 22, 2020
Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell MalignanciesFeng Zhu, Guoqing Wei, Mingming Zhang, et al.
Bone Marrow Transplantation|September 18, 2020
Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapyRuimin Hong, Houli Zhao, Yiyun Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2022
Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective studyShuyi Ding, Lingxia Cai, Aiyun Jin, et al.
Journal of Cancer|August 18, 2021
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatmentLinghui Zhou, Houli Zhao, Yang Shao, et al.
Bone Marrow Transplantation|February 21, 2025
Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective studyHaiqiong Zheng, Shi Han, Yijin Chen, et al.
Pageof 4